Cost Analyst IV

• Compensation: USD 130,000 - USD 140,000 - yearly

Bryce Tech is a trusted leader in complex technology domains, delivering data-driven solutions in aerospace, biosecurity, and defense. We specialize in systems engineering, advanced analytics, R&D programs, and strategic advisory support. Our clients – including NASA, DoW, HHS, DHS, and other civil and national security agencies – rely on us to drive mission success and accelerate innovation.

Bryce Tech has been recognized in the Washington Technology Fast 50 ranking of top high-growth small businesses for five consecutive years and received a Gov Con Contractor of the Year Award in 2025, underscoring our strong growth, competitive positioning, and excellence in federal contracting. With a proven track record of winning sought-after contracts, scaling high-performance teams, and executing on critical government missions, Bryce Tech presents a compelling opportunity for strategic partnerships in the Gov Con space.

Bryce Tech is currently looking for a Cost Analyst IV. This position will be supporting Capability Program Executive for Chemical, Biological Radiological Nuclear Defense – Medical (CPE CBRND - JPM Med). This role will provide cost analysis support to Government project leads for CONUS and OCONUS missions, to include travel when needed.

The Person in this role will:

• Create, review and analyze cost estimates using the automated cost estimating integrated tool (ACEIT) suite.
• Provide comprehensive cost analysis modeling support, to include:
  • Independent analysis of requirements
  • Correct application of cost estimating methodologies
  • Developing logical cost estimates that are defensible and supportable
  • Presenting a summary of resulting analyses to internal and external audiences
  • Reviewing and analyzing monthly contractor EVM data
• Develop and execute the application of cost models suitable for prediction and analysis of budgetary requirements for medical product development, inclusive of costs associated with FDA processes and regulatory compliance, clinical trials, drug manufacturing, laboratory testing, and development of drugs leading to FDA approval/licensure.
• Incorporate relevant data from the ACE-IT suite, to include the Automated Cost Estimator (ACE), Joint Analysis of Cost and Schedule (JACS), Risk modules, and the Program Office Support Tool (POST) into cost estimates.
• Analyze as necessary Microsoft Excel cost models, to include use of risk analysis tool add-ins (e.g., Crystal Ball, @Risk, etc.).
• Review or analyze as necessary Joint cost/schedule uncertainty analyses and obtaining cost model result outputs.
• Provide cost estimating support at the portfolio level, to include developing portfolio models that integrate and display time-phased cost and schedule risk-adjusted views of multiple acquisition systems.
• Assist in development of and analyze cost and schedule risk adjusted life‑cycle cost estimates (LCCEs), Independent Government Cost Estimates (IGCEs), Business Case Analyses (BCAs), Analysis of Alternatives (AoAs), program office estimates, and other cost analyses.
• Brief executive leadership on program cost positions, impact of budget changes on supported programs, and other cost issues.
• Assist in the development of budget submissions (Procurement (P)- Forms, Research Development Test and Evaluation (R)-Forms, etc.).
• Possess experience developing briefings and presentations.
• Develop cost models for JPM Medical level cost positions, and build and maintain cost estimate portfolios.
• Conduct pre‑validation (sufficiency reviews) of all cost estimates (IGCE, LCCE, Cost Benefit Analysis (CBA), Will/Should Cost Analyses) prior to being sent to the JPEO‑CBRND Headquarters for formal/external validation.
• Pre‑validate…